Q3695265 (Q3695265): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy., translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) | |||||||||||||||
Property / summary: The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English) / qualifier | |||||||||||||||
point in time: 18 November 2021
|
Revision as of 19:04, 18 November 2021
Project Q3695265 in France
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3695265 in France |
Statements
182,127.0 Euro
0 references
404,728.53 Euro
0 references
45.0 percent
0 references
18 March 2016
0 references
31 October 2018
0 references
Université de Bourgogne
0 references
Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
0 references
The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
18 November 2021
0 references
Identifiers
BG0005829
0 references